Cargando…

Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy

BACKGROUND: The etiology of dilated cardiomyopathy (DCM) is unclear. Bioinformatics algorithms may help to explore the underlying mechanisms. Therefore, we aimed to screen diagnostic biomarkers and identify the landscape of immune infiltration in DCM. METHODS: First, the CIBERSORT algorithm was used...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qingquan, Fan, Mengkang, Cao, Xueyan, Geng, Haihua, Su, Yamin, Wu, Chunyu, Pan, Haiyan, Pan, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010553/
https://www.ncbi.nlm.nih.gov/pubmed/35433865
http://dx.doi.org/10.3389/fcvm.2022.809470
_version_ 1784687502581301248
author Zhang, Qingquan
Fan, Mengkang
Cao, Xueyan
Geng, Haihua
Su, Yamin
Wu, Chunyu
Pan, Haiyan
Pan, Min
author_facet Zhang, Qingquan
Fan, Mengkang
Cao, Xueyan
Geng, Haihua
Su, Yamin
Wu, Chunyu
Pan, Haiyan
Pan, Min
author_sort Zhang, Qingquan
collection PubMed
description BACKGROUND: The etiology of dilated cardiomyopathy (DCM) is unclear. Bioinformatics algorithms may help to explore the underlying mechanisms. Therefore, we aimed to screen diagnostic biomarkers and identify the landscape of immune infiltration in DCM. METHODS: First, the CIBERSORT algorithm was used to excavate the proportion of immune-infiltration cells in DCM and normal myocardial tissues. Meanwhile, the Pearson analysis and principal component analysis (PCA) were used to identify immune heterogeneity in different tissues. The Wilcoxon test, LASSO regression, and machine learning method were conducted to identify the hub immune cells. In addition, the differentially expressed genes (DEGs) were screened by the limma package, and DEGs were analyzed for functional enrichment. In the protein–protein interaction (PPI) network, multiple algorithms were used to calculate the score of each DEG for screening the hub genes. Subsequently, external datasets were used to further validate the expression of hub genes, and the receiver operating characteristic (ROC) curve was used to analyze the diagnostic efficacy. Finally, we examined the expression of hub biomarkers in animal models. RESULTS: A total of 108 DEGs were screened, and these genes may be related to biological processes such as cytolysis, positive regulation of cytokine secretion, etc. Two types of hub immune cells [activated natural killer (NK) cells and eosinophils] and four hub genes (ASPN, CD163, IL10, and LUM) were identified in DCM myocardial tissues. CD163 was verified to have the capability to diagnose DCM with the most excellent specificity and sensitivity. It is worth mentioning that the combined CD163 and eosinophils may have better diagnostic efficacy. Moreover, the correlation analysis showed CD163 was negatively correlated with activated NK cells. Finally, the results of the mice model also indicated that CD163 might be involved in the occurrence of DCM. CONCLUSION: ASPN, CD163, IL10, and LUM may have a potential predictive ability for DCM, and especially CD163 showed the most robust efficacy. Furthermore, activated NK cells and eosinophils may relate to the occurrence of DCM.
format Online
Article
Text
id pubmed-9010553
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90105532022-04-16 Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy Zhang, Qingquan Fan, Mengkang Cao, Xueyan Geng, Haihua Su, Yamin Wu, Chunyu Pan, Haiyan Pan, Min Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: The etiology of dilated cardiomyopathy (DCM) is unclear. Bioinformatics algorithms may help to explore the underlying mechanisms. Therefore, we aimed to screen diagnostic biomarkers and identify the landscape of immune infiltration in DCM. METHODS: First, the CIBERSORT algorithm was used to excavate the proportion of immune-infiltration cells in DCM and normal myocardial tissues. Meanwhile, the Pearson analysis and principal component analysis (PCA) were used to identify immune heterogeneity in different tissues. The Wilcoxon test, LASSO regression, and machine learning method were conducted to identify the hub immune cells. In addition, the differentially expressed genes (DEGs) were screened by the limma package, and DEGs were analyzed for functional enrichment. In the protein–protein interaction (PPI) network, multiple algorithms were used to calculate the score of each DEG for screening the hub genes. Subsequently, external datasets were used to further validate the expression of hub genes, and the receiver operating characteristic (ROC) curve was used to analyze the diagnostic efficacy. Finally, we examined the expression of hub biomarkers in animal models. RESULTS: A total of 108 DEGs were screened, and these genes may be related to biological processes such as cytolysis, positive regulation of cytokine secretion, etc. Two types of hub immune cells [activated natural killer (NK) cells and eosinophils] and four hub genes (ASPN, CD163, IL10, and LUM) were identified in DCM myocardial tissues. CD163 was verified to have the capability to diagnose DCM with the most excellent specificity and sensitivity. It is worth mentioning that the combined CD163 and eosinophils may have better diagnostic efficacy. Moreover, the correlation analysis showed CD163 was negatively correlated with activated NK cells. Finally, the results of the mice model also indicated that CD163 might be involved in the occurrence of DCM. CONCLUSION: ASPN, CD163, IL10, and LUM may have a potential predictive ability for DCM, and especially CD163 showed the most robust efficacy. Furthermore, activated NK cells and eosinophils may relate to the occurrence of DCM. Frontiers Media S.A. 2022-04-01 /pmc/articles/PMC9010553/ /pubmed/35433865 http://dx.doi.org/10.3389/fcvm.2022.809470 Text en Copyright © 2022 Zhang, Fan, Cao, Geng, Su, Wu, Pan and Pan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Zhang, Qingquan
Fan, Mengkang
Cao, Xueyan
Geng, Haihua
Su, Yamin
Wu, Chunyu
Pan, Haiyan
Pan, Min
Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy
title Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy
title_full Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy
title_fullStr Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy
title_full_unstemmed Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy
title_short Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy
title_sort integrated bioinformatics algorithms and experimental validation to explore robust biomarkers and landscape of immune cell infiltration in dilated cardiomyopathy
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010553/
https://www.ncbi.nlm.nih.gov/pubmed/35433865
http://dx.doi.org/10.3389/fcvm.2022.809470
work_keys_str_mv AT zhangqingquan integratedbioinformaticsalgorithmsandexperimentalvalidationtoexplorerobustbiomarkersandlandscapeofimmunecellinfiltrationindilatedcardiomyopathy
AT fanmengkang integratedbioinformaticsalgorithmsandexperimentalvalidationtoexplorerobustbiomarkersandlandscapeofimmunecellinfiltrationindilatedcardiomyopathy
AT caoxueyan integratedbioinformaticsalgorithmsandexperimentalvalidationtoexplorerobustbiomarkersandlandscapeofimmunecellinfiltrationindilatedcardiomyopathy
AT genghaihua integratedbioinformaticsalgorithmsandexperimentalvalidationtoexplorerobustbiomarkersandlandscapeofimmunecellinfiltrationindilatedcardiomyopathy
AT suyamin integratedbioinformaticsalgorithmsandexperimentalvalidationtoexplorerobustbiomarkersandlandscapeofimmunecellinfiltrationindilatedcardiomyopathy
AT wuchunyu integratedbioinformaticsalgorithmsandexperimentalvalidationtoexplorerobustbiomarkersandlandscapeofimmunecellinfiltrationindilatedcardiomyopathy
AT panhaiyan integratedbioinformaticsalgorithmsandexperimentalvalidationtoexplorerobustbiomarkersandlandscapeofimmunecellinfiltrationindilatedcardiomyopathy
AT panmin integratedbioinformaticsalgorithmsandexperimentalvalidationtoexplorerobustbiomarkersandlandscapeofimmunecellinfiltrationindilatedcardiomyopathy